Which has higher valuation and earnings, EXE or SIA?

Extendicare has higher revenue and earnings than Sienna Senior Living. Extendicare is trading at a lower price-to-earnings ratio than Sienna Senior Living, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Extendicare C$1.75B 2.01 C$65.46M C$1.36 27.30 Sienna Senior Living C$1.05B 2.33 C$33.51M C$0.48 47.81

Does the media refer more to EXE or SIA?

In the previous week, Sienna Senior Living had 1 more articles in the media than Extendicare. MarketBeat recorded 2 mentions for Sienna Senior Living and 1 mentions for Extendicare. Sienna Senior Living's average media sentiment score of 1.27 beat Extendicare's score of 0.00 indicating that Sienna Senior Living is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Extendicare 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Sienna Senior Living 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger earnings & valuation, DNTL or EXE?

Extendicare has higher revenue and earnings than dentalcorp. dentalcorp is trading at a lower price-to-earnings ratio than Extendicare, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio dentalcorp C$1.66B 1.32 -C$80.68M -C$0.14 N/A Extendicare C$1.75B 2.01 C$65.46M C$1.36 27.30

Does the media favor DNTL or EXE?

In the previous week, dentalcorp and dentalcorp both had 1 articles in the media. dentalcorp's average media sentiment score of 0.00 equaled Extendicare'saverage media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment dentalcorp 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Extendicare 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media prefer EXE or WELL?

In the previous week, WELL Health Technologies had 2 more articles in the media than Extendicare. MarketBeat recorded 3 mentions for WELL Health Technologies and 1 mentions for Extendicare. WELL Health Technologies' average media sentiment score of 0.82 beat Extendicare's score of 0.00 indicating that WELL Health Technologies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Extendicare 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral WELL Health Technologies 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate EXE or DR?

Extendicare currently has a consensus target price of C$32.56, indicating a potential downside of 12.25%. Given Extendicare's stronger consensus rating and higher possible upside, research analysts plainly believe Extendicare is more favorable than Medical Facilities. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Extendicare 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 2 Strong Buy rating(s) 3.25 Medical Facilities 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has better earnings & valuation, EXE or DR?

Extendicare has higher revenue and earnings than Medical Facilities. Medical Facilities is trading at a lower price-to-earnings ratio than Extendicare, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Extendicare C$1.75B 2.01 C$65.46M C$1.36 27.30 Medical Facilities C$260.72M 1.22 C$17.17M C$1.94 9.36

Do analysts prefer NLH or EXE?

Extendicare has a consensus target price of C$32.56, indicating a potential downside of 12.25%. Given Extendicare's stronger consensus rating and higher possible upside, analysts plainly believe Extendicare is more favorable than Nova Leap Health. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nova Leap Health 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Extendicare 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 2 Strong Buy rating(s) 3.25

Which has preferable valuation & earnings, NLH or EXE?

Extendicare has higher revenue and earnings than Nova Leap Health. Extendicare is trading at a lower price-to-earnings ratio than Nova Leap Health, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Nova Leap Health C$32.23M 1.03 -C$300.30K C$0.00 126.67 Extendicare C$1.75B 2.01 C$65.46M C$1.36 27.30

Extendicare (EXE) Competitors

C$37.10 +0.08 (+0.22%)

As of 04:00 PM Eastern

Compare

EXE vs. SIA, DNTL, WELL, DR, and NLH

Should you buy Extendicare stock or one of its competitors? MarketBeat compares Extendicare with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Extendicare include Sienna Senior Living (SIA), dentalcorp (DNTL), WELL Health Technologies (WELL), Medical Facilities (DR), and Nova Leap Health (NLH). These companies are all part of the "medical care facilities" industry.

How does Extendicare compare to Sienna Senior Living?

Extendicare (TSE:EXE) and Sienna Senior Living (TSE:SIA) are both mid-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, earnings, media sentiment, valuation, dividends, profitability, risk and analyst recommendations.

Extendicare has a net margin of 6.99% compared to Sienna Senior Living's net margin of 4.34%. Extendicare's return on equity of 45.35% beat Sienna Senior Living's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Extendicare	6.99%	45.35%	7.16%
Sienna Senior Living	4.34%	6.44%	3.58%

Extendicare has higher revenue and earnings than Sienna Senior Living. Extendicare is trading at a lower price-to-earnings ratio than Sienna Senior Living, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Extendicare	C$1.75B	2.01	C$65.46M	C$1.36	27.30
Sienna Senior Living	C$1.05B	2.33	C$33.51M	C$0.48	47.81

Extendicare has a beta of 1.580825, indicating that its stock price is 58% more volatile than the broader market. Comparatively, Sienna Senior Living has a beta of 1.059779, indicating that its stock price is 6% more volatile than the broader market.

Extendicare pays an annual dividend of C$0.51 per share and has a dividend yield of 1.4%. Sienna Senior Living pays an annual dividend of C$0.94 per share and has a dividend yield of 4.1%. Extendicare pays out 37.2% of its earnings in the form of a dividend. Sienna Senior Living pays out 195.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

In the previous week, Sienna Senior Living had 1 more articles in the media than Extendicare. MarketBeat recorded 2 mentions for Sienna Senior Living and 1 mentions for Extendicare. Sienna Senior Living's average media sentiment score of 1.27 beat Extendicare's score of 0.00 indicating that Sienna Senior Living is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Extendicare	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Sienna Senior Living	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Extendicare currently has a consensus target price of C$32.56, suggesting a potential downside of 12.25%. Sienna Senior Living has a consensus target price of C$26.09, suggesting a potential upside of 13.69%. Given Sienna Senior Living's higher probable upside, analysts plainly believe Sienna Senior Living is more favorable than Extendicare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Extendicare	0 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	2 Strong Buy rating(s)	3.25
Sienna Senior Living	0 Sell rating(s)	1 Hold rating(s)	9 Buy rating(s)	1 Strong Buy rating(s)	3.00

25.1% of Extendicare shares are held by institutional investors. Comparatively, 28.0% of Sienna Senior Living shares are held by institutional investors. 13.9% of Extendicare shares are held by company insiders. Comparatively, 0.1% of Sienna Senior Living shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Summary

Extendicare beats Sienna Senior Living on 11 of the 19 factors compared between the two stocks.

How does Extendicare compare to dentalcorp?

dentalcorp (TSE:DNTL) and Extendicare (TSE:EXE) are both mid-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their risk, valuation, institutional ownership, earnings, analyst recommendations, dividends, profitability and media sentiment.

dentalcorp pays an annual dividend of C$0.08 per share and has a dividend yield of 0.7%. Extendicare pays an annual dividend of C$0.51 per share and has a dividend yield of 1.4%. dentalcorp pays out -53.6% of its earnings in the form of a dividend. Extendicare pays out 37.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

dentalcorp has a beta of 1.469634, suggesting that its share price is 47% more volatile than the broader market. Comparatively, Extendicare has a beta of 1.580825, suggesting that its share price is 58% more volatile than the broader market.

Extendicare has a net margin of 6.99% compared to dentalcorp's net margin of -1.12%. Extendicare's return on equity of 45.35% beat dentalcorp's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
dentalcorp	-1.12%	-0.80%	0.77%
Extendicare	6.99%	45.35%	7.16%

Extendicare has higher revenue and earnings than dentalcorp. dentalcorp is trading at a lower price-to-earnings ratio than Extendicare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
dentalcorp	C$1.66B	1.32	-C$80.68M	-C$0.14	N/A
Extendicare	C$1.75B	2.01	C$65.46M	C$1.36	27.30

In the previous week, dentalcorp and dentalcorp both had 1 articles in the media. dentalcorp's average media sentiment score of 0.00 equaled Extendicare'saverage media sentiment score.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
dentalcorp	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Extendicare	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

dentalcorp currently has a consensus target price of C$11.00, indicating a potential upside of 0.00%. Extendicare has a consensus target price of C$32.56, indicating a potential downside of 12.25%. Given dentalcorp's higher probable upside, analysts plainly believe dentalcorp is more favorable than Extendicare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
dentalcorp	1 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.80
Extendicare	0 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	2 Strong Buy rating(s)	3.25

17.9% of dentalcorp shares are held by institutional investors. Comparatively, 25.1% of Extendicare shares are held by institutional investors. 0.2% of dentalcorp shares are held by insiders. Comparatively, 13.9% of Extendicare shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

Extendicare beats dentalcorp on 15 of the 17 factors compared between the two stocks.

How does Extendicare compare to WELL Health Technologies?

Extendicare (TSE:EXE) and WELL Health Technologies (TSE:WELL) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, analyst recommendations, risk, earnings, profitability, institutional ownership, media sentiment and valuation.

Extendicare has a net margin of 6.99% compared to WELL Health Technologies' net margin of 1.82%. Extendicare's return on equity of 45.35% beat WELL Health Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Extendicare	6.99%	45.35%	7.16%
WELL Health Technologies	1.82%	3.15%	2.07%

WELL Health Technologies has lower revenue, but higher earnings than Extendicare. Extendicare is trading at a lower price-to-earnings ratio than WELL Health Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Extendicare	C$1.75B	2.01	C$65.46M	C$1.36	27.30
WELL Health Technologies	C$1.47B	0.73	C$73.76M	C$0.11	38.27

25.1% of Extendicare shares are owned by institutional investors. Comparatively, 5.4% of WELL Health Technologies shares are owned by institutional investors. 13.9% of Extendicare shares are owned by insiders. Comparatively, 6.8% of WELL Health Technologies shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Extendicare presently has a consensus price target of C$32.56, indicating a potential downside of 12.25%. WELL Health Technologies has a consensus price target of C$7.13, indicating a potential upside of 69.24%. Given WELL Health Technologies' higher possible upside, analysts plainly believe WELL Health Technologies is more favorable than Extendicare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Extendicare	0 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	2 Strong Buy rating(s)	3.25
WELL Health Technologies	0 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	3.00

In the previous week, WELL Health Technologies had 2 more articles in the media than Extendicare. MarketBeat recorded 3 mentions for WELL Health Technologies and 1 mentions for Extendicare. WELL Health Technologies' average media sentiment score of 0.82 beat Extendicare's score of 0.00 indicating that WELL Health Technologies is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Extendicare	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
WELL Health Technologies	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Extendicare has a beta of 1.580825, suggesting that its share price is 58% more volatile than the broader market. Comparatively, WELL Health Technologies has a beta of 0.900556, suggesting that its share price is 10% less volatile than the broader market.

Summary

Extendicare beats WELL Health Technologies on 12 of the 17 factors compared between the two stocks.

How does Extendicare compare to Medical Facilities?

Extendicare (TSE:EXE) and Medical Facilities (TSE:DR) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, media sentiment, risk, earnings, analyst recommendations, dividends, institutional ownership and profitability.

Medical Facilities has a net margin of 14.01% compared to Extendicare's net margin of 6.99%. Medical Facilities' return on equity of 51.33% beat Extendicare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Extendicare	6.99%	45.35%	7.16%
Medical Facilities	14.01%	51.33%	13.60%

Extendicare has higher revenue and earnings than Medical Facilities. Medical Facilities is trading at a lower price-to-earnings ratio than Extendicare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Extendicare	C$1.75B	2.01	C$65.46M	C$1.36	27.30
Medical Facilities	C$260.72M	1.22	C$17.17M	C$1.94	9.36

In the previous week, Extendicare had 1 more articles in the media than Medical Facilities. MarketBeat recorded 1 mentions for Extendicare and 0 mentions for Medical Facilities. Extendicare's average media sentiment score of 0.00 equaled Medical Facilities'average media sentiment score.

Company	Overall Sentiment
Extendicare	Neutral
Medical Facilities	Neutral

25.1% of Extendicare shares are held by institutional investors. Comparatively, 15.9% of Medical Facilities shares are held by institutional investors. 13.9% of Extendicare shares are held by company insiders. Comparatively, 0.4% of Medical Facilities shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Extendicare has a beta of 1.580825, meaning that its share price is 58% more volatile than the broader market. Comparatively, Medical Facilities has a beta of 0.496135, meaning that its share price is 50% less volatile than the broader market.

Extendicare currently has a consensus target price of C$32.56, indicating a potential downside of 12.25%. Given Extendicare's stronger consensus rating and higher possible upside, research analysts plainly believe Extendicare is more favorable than Medical Facilities.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Extendicare	0 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	2 Strong Buy rating(s)	3.25
Medical Facilities	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Extendicare pays an annual dividend of C$0.51 per share and has a dividend yield of 1.4%. Medical Facilities pays an annual dividend of C$0.26 per share and has a dividend yield of 1.4%. Extendicare pays out 37.2% of its earnings in the form of a dividend. Medical Facilities pays out 13.4% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Medical Facilities is clearly the better dividend stock, given its higher yield and lower payout ratio.

Summary

Extendicare beats Medical Facilities on 12 of the 18 factors compared between the two stocks.

How does Extendicare compare to Nova Leap Health?

Nova Leap Health (CVE:NLH) and Extendicare (TSE:EXE) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, analyst recommendations, media sentiment, profitability, institutional ownership, earnings, valuation and dividends.

Nova Leap Health has a beta of 1.695796, suggesting that its stock price is 70% more volatile than the broader market. Comparatively, Extendicare has a beta of 1.580825, suggesting that its stock price is 58% more volatile than the broader market.

Extendicare has a consensus target price of C$32.56, indicating a potential downside of 12.25%. Given Extendicare's stronger consensus rating and higher possible upside, analysts plainly believe Extendicare is more favorable than Nova Leap Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nova Leap Health	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Extendicare	0 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	2 Strong Buy rating(s)	3.25

Extendicare has a net margin of 6.99% compared to Nova Leap Health's net margin of 0.64%. Extendicare's return on equity of 45.35% beat Nova Leap Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Nova Leap Health	0.64%	1.10%	2.77%
Extendicare	6.99%	45.35%	7.16%

0.0% of Nova Leap Health shares are owned by institutional investors. Comparatively, 25.1% of Extendicare shares are owned by institutional investors. 40.8% of Nova Leap Health shares are owned by company insiders. Comparatively, 13.9% of Extendicare shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

In the previous week, Extendicare had 1 more articles in the media than Nova Leap Health. MarketBeat recorded 1 mentions for Extendicare and 0 mentions for Nova Leap Health. Nova Leap Health's average media sentiment score of 0.00 equaled Extendicare'saverage media sentiment score.

Company	Overall Sentiment
Nova Leap Health	Neutral
Extendicare	Neutral

Extendicare has higher revenue and earnings than Nova Leap Health. Extendicare is trading at a lower price-to-earnings ratio than Nova Leap Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nova Leap Health	C$32.23M	1.03	-C$300.30K	C$0.00	126.67
Extendicare	C$1.75B	2.01	C$65.46M	C$1.36	27.30

Summary

Extendicare beats Nova Leap Health on 13 of the 16 factors compared between the two stocks.

Get Extendicare News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding EXE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

EXE vs. The Competition

Export

Metric	Extendicare	Medical Care Facilities Industry	Medical Sector	TSE Exchange
Market Cap	C$3.52B	C$1.67B	C$6.73B	C$12.29B
Dividend Yield	1.38%	3.88%	2.68%	6.17%
P/E Ratio	27.30	12.62	27.01	36.35
Price / Sales	2.01	17.88	584.16	9.83
Price / Cash	3.20	7.90	29.22	82.29
Price / Book	9.00	1.86	10.81	4.49
Net Income	C$65.46M	C$63.03M	C$3.58B	C$299.09M
7 Day Performance	0.27%	0.94%	-2.24%	-0.06%
1 Month Performance	13.53%	4.48%	3.12%	-0.40%
1 Year Performance	180.21%	15.22%	26.33%	31.76%

Extendicare Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
EXE Extendicare	1.3233 of 5 stars	C$37.10 +0.2%	C$32.56 -12.2%	+180.0%	C$3.52B	C$1.75B	27.30	23,000
SIA Sienna Senior Living	3.0667 of 5 stars	C$23.14 +0.3%	C$26.09 +12.8%	+21.9%	C$2.46B	C$1.05B	48.21	12,000	News Coverage Positive News High Trading Volume
DNTL dentalcorp	0.0335 of 5 stars	C$11.00 +0.1%	C$11.00	+35.8%	C$2.19B	C$1.66B	N/A	9,950
WELL WELL Health Technologies	2.7928 of 5 stars	C$4.26 +0.9%	C$6.92 +62.4%	-7.7%	C$1.08B	C$1.47B	38.73	510
DR Medical Facilities	N/A	C$18.32 +0.1%	N/A	+14.9%	C$321.52M	C$260.72M	9.44	1,833

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (TSE:EXE) was last updated on 7/14/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Extendicare (EXE) Competitors

EXE vs. SIA, DNTL, WELL, DR, and NLH

How does Extendicare compare to Sienna Senior Living?

Summary

How does Extendicare compare to dentalcorp?

Summary

How does Extendicare compare to WELL Health Technologies?

Summary

How does Extendicare compare to Medical Facilities?

Summary

How does Extendicare compare to Nova Leap Health?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

EXE vs. The Competition

Extendicare Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Extendicare (EXE) Competitors

EXE vs. SIA, DNTL, WELL, DR, and NLH

How does Extendicare compare to Sienna Senior Living?

Is EXE or SIA more profitable?

Which has higher valuation and earnings, EXE or SIA?

Which has more volatility and risk, EXE or SIA?

Is EXE or SIA a better dividend stock?

Does the media refer more to EXE or SIA?

Do analysts rate EXE or SIA?

Do institutionals & insiders believe in EXE or SIA?

Summary

How does Extendicare compare to dentalcorp?

Is DNTL or EXE a better dividend stock?

Which has more volatility and risk, DNTL or EXE?

Is DNTL or EXE more profitable?

Which has stronger earnings & valuation, DNTL or EXE?

Does the media favor DNTL or EXE?

Do analysts recommend DNTL or EXE?

Do insiders and institutionals have more ownership in DNTL or EXE?

Summary

How does Extendicare compare to WELL Health Technologies?

Is EXE or WELL more profitable?

Which has preferable earnings and valuation, EXE or WELL?

Do institutionals and insiders believe in EXE or WELL?

Do analysts prefer EXE or WELL?

Does the media prefer EXE or WELL?

Which has more risk & volatility, EXE or WELL?

Summary

How does Extendicare compare to Medical Facilities?

Is EXE or DR more profitable?

Which has better earnings & valuation, EXE or DR?

Does the media favor EXE or DR?

Do insiders and institutionals have more ownership in EXE or DR?

Which has more risk & volatility, EXE or DR?

Do analysts rate EXE or DR?

Is EXE or DR a better dividend stock?

Summary

How does Extendicare compare to Nova Leap Health?

Which has more risk & volatility, NLH or EXE?

Do analysts prefer NLH or EXE?

Is NLH or EXE more profitable?

Do insiders and institutionals believe in NLH or EXE?

Does the media prefer NLH or EXE?

Which has preferable valuation & earnings, NLH or EXE?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

EXE vs. The Competition

Extendicare Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools